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Background: Network biology currently focuses primarily on metabolic pathways, gene regulatory, and protein-protein
interaction networks. While these approaches have yielded critical information, alternative methods to network analysis
will offer new perspectives on biological information. A little explored area is the interactions between domains that can
be captured using domain co-occurrence networks (DCN). A DCN can be used to study the function and interaction of
proteins by representing protein domains and their co-existence in genes and by mapping cancer mutations to the
individual protein domains to identify signals.
Results: The domain co-occurrence network was constructed for the human proteome based on PFAM domains in
proteins. Highly connected domains in the central cores were identified using the k-core decomposition technique. Here
we show that these domains were found to be more evolutionarily conserved than the peripheral domains. The somatic
mutations for ovarian, breast and prostate cancer diseases were obtained from the TCGA database. We mapped the
somatic mutations to the individual protein domains and the local false discovery rate was used to identify significantly
mutated domains in each cancer type. Significantly mutated domains were found to be enriched in cancer disease
pathways. However, we found that the inner cores of the DCN did not contain any of the significantly mutated domains.
We observed that the inner core protein domains are highly conserved and these domains co-exist in large numbers with
other protein domains.
Conclusion: Mutations and domain co-occurrence networks provide a framework for understanding hierarchal designs
in protein function from a network perspective. This study provides evidence that a majority of protein domains in the
inner core of the DCN have a lower mutation frequency and that protein domains present in the peripheral regions of
the k-core contribute more heavily to the disease. These findings may contribute further to drug development.
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Domains are distinct functional or structural units in a
protein. Most domains correspond to tertiary structure
elements, and are able to fold independently. All protein
domains exhibit evolutionary conservation and many
either perform specific functions or contribute in a
specific way to the structure of their proteins. Domains
may exist in a variety of biological contexts, wherein
similar domains can be found in proteins with different* Correspondence: jom2042@qatar-med.cornell.edu
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unless otherwise stated.functions. Many proteins are composed of one or more
domains that can fold independently into a stable core
structure [1-3].
Many complex systems have been analyzed as networks
by representing the system as nodes and interactions be-
tween them as edges. Studies on complex networks in-
cluding the network of co-authorships, sexual contacts
and the world-wide-web (WWW) reveal that their struc-
ture and growth is governed by a set of generic organizing
principles [4,5]. Network biology is emerging as a new
field in biology due to the increasing availability of
genome-scale data sets of molecular interactions. These
data are a result of new high-throughput technologies
yielding information on protein interactions, regulatoryal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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gene interaction networks, protein and metabolite
networks have been found to exhibit a scale-free prop-
erty [6-13].
The development of high-throughput, whole-exome/
genome DNA sequencing has made it possible to evalu-
ate normal and tumor tissue samples in a single study.
These studies have revealed the connection between
somatic mutations and cancer susceptibility, initiation
and development [14]. A central goal of cancer genome
analysis is the identification of cancer genes that, by def-
inition, carry driver mutations. A key challenge will
therefore be to distinguish driver from passenger muta-
tions. Most studies thus far have attempted to identify
driver mutations using gene-centric approaches [15-20].
Unfortunately, this method is limited to a small subset
of genes and also leads to mischaracterized mutations
[21]. The gene-based approach usually fails to reflect the
position of mutation or the functional context the pos-
ition of mutation provides in protein level. But a protein
domain network enables the identification of mutations
that are rare at the gene level, but that occur frequently
within the specified domain. These highly mutated do-
mains potentially reveal disruptions of protein function
necessary for cancer development.
Several studies have been conducted on protein do-
main co-occurrence networks (DCN). These studies rep-
resent domains as nodes and their co-occurrence in a
protein are denoted as edges. The networks have also
been shown to possess a scale-free property [22-24]. In-
creasing complexity of the organisms were observed
from bacteria to eukaryotes due to the links involved in
the cell-cell interaction domains, signal transduction and
cell differentiation domains. Studies on DCN have exam-
ined the network property [22], evolutionary traces
among the species [25], architectural design of protein
domain networks [26] and mapping somatic mutations
to protein domains in colon cancer [27]. More recently,
a disease-drug-phenotype matrix was also analyzed using
protein domain networks [28]. However, each of these
studies have focused either on domain co-occurrence
networks or on a specific feature of the DCN and there-
fore, do not provide a generalized view of mutations in
the domain co-occurrence network. In this study, we in-
vestigated the protein domain co-occurrence network in
the context of various cancers and their mutations. We
specifically focused on the highly connected protein do-
mains of the DCN core by using k-core decomposition
techniques.
The definition of k-core was first introduced by Seid-
man [29] to characterize the cohesive regions of graphs.
Batagelj et al., developed an efficient algorithm to find
the k-core decomposition of a graph [30]. K-core tech-
nique has been used in many areas including thealternative method for community detection algorithm
[31] and for the identification of dense components in
most of the complex networks [32-34].
K-core decomposition is a network analysis approach
that helps in understanding interesting structural prop-
erties that are not otherwise captured by many other
network topological parameters. The basic principle be-
hind the k-core is decomposition to identify particular
subsets of the network called k-cores. Each k-core is ob-
tained by a recursive pruning method [29,35,36]. This
decomposition method allows the study of the hierarch-
ical properties of large complex networks by focusing on
the network centrality and connectedness properties of
nodes. The central cores of this analysis have more
strongly connected vertices with large number of pos-
sible distinct paths between them. This helps in obtain-
ing robust routing properties.Materials and methods
Construction of protein domain co-occurrence
networks (DCN)
The DCN for Homo sapiens was constructed using the
Ensembl database (version 72) that provides a compre-
hensive source of stable automatic annotation of individ-
ual genomes [37].
To ensure correct coordinates in our version domains
present in any protein sequence of the human proteome
were determined using the program PfamScan [38].
Domain hits with an e-value < =0.01 were considered for
constructing a DCN. Each domain was represented as a
node and if every two domains co-exist in one protein
then they were connected by edges as shown in Figure 1
[25]. Figure 2 illustrates the largest sub-graph for H.
sapiens consisting of 1929 nodes and 5171 edges as visu-
alized by Cytoscape [39].K-core decomposition of DCN
To identify the core-periphery organization of the do-
main co-occurrence network, we subjected it to core
decomposition. The cores of different orders of a net-
work can be obtained by iteratively removing all nodes
which have less than k connections with other protein
domains (k = 1, 2, …). This is done by first identifying
all nodes whose degree (i.e., number of connections) is
less than k. After removing these, the network is re-
analyzed to determine if the removal of these nodes
has resulted in other nodes (which originally had de-
gree > k) having now less than k connections. If such
nodes are identified, then they are removed, and the
process is continued, until no more nodes can be re-
moved. The resulting sub-network is called the k-core
of the network.
Figure 1 A small DCN consisting of two H. sapiens proteins. The two proteins share the same domain C1-set. An edge is drawn between
domains co-occurring in the same protein and a fully connected sub-graph (clique) in the DCN corresponds to a protein.
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To determine the statistical significance of the properties
calculated for members of an empirically determined
k-core, we compared them with the mean and variance
of the corresponding values obtained for a randomized
ensemble. Each randomized k-core in the ensemble is
obtained by random selection without replacement of
Nk domains from the DCN, where Nk is the size of the
empirically determined k-core. The randomized ensem-
ble for every DCN considered was generated by con-
structing 100 such randomized k-cores.Evolutionary conservation of protein domains
The evolutionary conserved protein domains were iden-
tified using the database PANDITplus [40]. It consists of
a database of PFAM alignment phylogenetic trees for
known protein domains and their families. This database
was constructed using a relational database which com-
prises of information regarding the functional categories,
metabolic pathways, protein–protein interactions, dis-
ease associations, gene expressions, three-dimensional
structures, as well as estimates from an evolutionary
analyses of selective pressures.Cancer mutation dataset
Somatic mutation data for ovarian, breast and prostate
cancer were obtained from TCGA data portal (http://
tcga-data.nci.nih.gov/tcga/) using mutation files from the
hgsc.bcm.edu_COAD.IlluminaGA_DNASeq.1 and hgsc.
bcm.edu_COAD.SOLiD_DNASeq.1 directories down-
loaded on March 30th, 2013. The silent and RNA muta-
tions were filtered out from the data set as they were
assumed unlikely to affect the cancer development.
Somatic mutation counts for ovarian cancer were foundto be 20,878. For breast and prostate cancer the values
were found to be 35,558 and 23,349.
Mapping cancer SNPs to individual protein domains
Before mapping mutations to the individual protein
domains, the protein domain positions need to be
converted into their chromosome positions. Mutations
obtained from TCGA data portal were reported with
genomic locations while predicted PFAM domains docu-
mented in peptide coordinates. A Perl program was
written using the ensemble Perl API module for convert-
ing the protein domain positions into chromosome
positions. The Pfam domains from Homo sapiens were
successfully mapped with the chromosome positions as
shown in the Additional file 1: Table S1. For ovarian
cancer sample set, almost one third of the mutations
(30%) occurred inside annotated protein domain regions.
Similarly 47.5% and 49.3% of all mutations in breast and
prostate cancer sample sets were observed to have oc-
curred inside the protein domain space (Table 1).
Procedure for normalizing the domain mutation
frequency
To determine the domains that are frequently mutated
in the human genome, we first obtained the count of
mutations that fell within each domain. Since larger do-
mains are generally expected to accumulate more muta-
tions than the shorter domains, we normalized the
domain mutation counts with domain length. This was
done by dividing domain mutations counts by the cumu-
lative length of the domain in the genome. That is, the
summed length of all occurrences of the domain in the
genome was used as total length. The normalized score
for all the three cancer types are shown in Additional file
2: Table S2.
Figure 2 Domain co-occurrence network of H. sapiens. (a) The largest DCN sub-graph or the main graph of H. -sapiens, which consists of 1929 nodes
and 5171 edges. (b) The enlarged partial view of H. sapiens main DCN, in which the domain WD40 (beta-transducin repeat) is represented as a hub.
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Table 1 Percentage of mapped mutations in three forms of cancer
S. No Cancer type No. of Mutations No. of mapped mutations Percentage
1 Ovarian 20,878 5,842 30%
2 Breast 35,558 16,887 47.5%
3 Prostate 23,349 11,502 49.3%
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Domain mutation counts were normalized with the cu-
mulative length of the domain in the genome. We then
obtained the relative frequencies from the normalized
values and these frequencies were used as success prob-
ability (p). This probability (p) was normalized using the
signal to noise ratio of the Bernoulli distribution, which
resulted in a normalized score, z and is given by
Z ¼ p=sqrt p 1−pð Þð Þ
The “locfdr” package [41] from R was used to esti-
mate the null distribution and these statistics were used
to identify domains with a local false discovery rate < 0.1
[42]. The local false discovery rate values for each
domain in all the three cancer types are shown in
Additional file 3: Table S3a (sheet1), Table S3b (sheet2)
and Table S3c (sheet3).
Results
Domains in the inner cores are more conserved than
those at the periphery
The domain co-occurrence network of Homo sapiens was
constructed and its statistical properties were determined.
From the degree distribution plot (Additional file 4: Figure
S1a), the DCN was found to have scale-free behavior.Figure 3 The percentage of conserved domains within each core ordAdditional file 4: Figure S1b shows the shortest path length
distribution exhibiting a small-world phenomenon.
The average clustering coefficient distributions and
the node degrees are found to have an inherent hier-
archical modularity (Additional file 4: Figure S1c). We
applied the k-core decomposition algorithm to the
Homo sapiens DCN [29]. The cores were found to
have 10 nested k-cores, where k values ranged from 1
to 10. The property of k-core decomposition is that as
the core increases the number of nodes in each core
decreases. This property was observed in the Homo
sapiens DCN.
To differentiate the protein domains in each core, we
first identified the conserved domains in each core using
PANDIT server. To verify whether the frequency of
conserved domains in the inner cores is statistically
significant, the empirical values were compared
against the randomized cores. The percentage of con-
served domains increased with increasing core order
in contrast to the random cores that did not show sig-
nificant deviations with the core order (Figure 3). The
deviation of the empirical data with core order is
much greater than the error bars obtained from the
random ensemble. This suggests that the highly con-
served nature of the inner core domains is significant
in the empirical DCN.er.
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at the periphery
Cancer mutations obtained from TCGA data portal were
mapped to the individual protein domains. The normal-
ized mutation score for each protein domain was also
calculated (for details see Methods). To study the muta-
tions in domain co-occurrence network, the normalized
mutation scores were assigned to all the nodes (i.e., pro-
tein domain) in the network. In order to understand the
nature of mutation in the Homo sapiens DCN we sub-
jected it to core decomposition. We found that the nor-
malized mutations per domain in each core gradually
decreased with the core order. This observation oc-
curred for all the three cancer types. To verify whether
the findings are statistically significant, we compared the
empirical DCN with its random counterparts. The pat-
tern observed in the Homo sapiens DCN was not found
in 100 random DCNs (i.e. p < 0.01).
As shown in Figure 4, the number of normalized mu-
tations per domain corresponding to the random cores
does not show any significant deviation with core order,
unlike the case for the empirical DCN. The deviation of
the empirical data with core order is much less than the
error bars obtained from the random model. This sug-
gests that the less mutated nature of the inner core
domains is significant. A similar study shows that the
domains in the inner cores of S.cerevisiae, C.elegans, D.
melanogaster, M.musculus and H. sapiens have been pre-
served during evolution. This high conservation of inner
core domains across species development may explain
why they are also less mutated in comparison to the per-
ipheral protein domains in cancer [25].
From the randomized simulations, we observed that
the inner core domains had lesser rates of mutation
compared to the peripheral cores. To verify if, the inner
core significantly differed from the other cores (we
wanted to investigate the extent to which this aspect was
true and to also identify outliers), every domain’s nor-
malized mutation rates were plotted against the k-core
values for the three types of cancers as shown in
Additional file 5: Figure S2 (2a-ovarian cancer, 2b-breast
cancer & 2c-prostate cancer). Results suggested that the
normalized mutation rates gradually declined with the
core order and the correlation values (R2) between them
were also found to be positive. Interestingly, the outlier
of the inner core is found to be more significant as it
comprises of lower mutation rates.
Identification of significant mutated domains
Significantly mutated domains in all of the three cancer
types were identified using the local false discovery rate.
On comparing the significantly mutated domains among
the cancer types, we found several domains common
between ovarian, breast and prostate cancer (Figure 5).The significantly different domains in all three cancers
are tabulated in the Additional file 6: Table S4. Interest-
ingly, we found that in all of the three cancer sets the
P53 domain scores the highest number of mutations.
Among all the cancer domains 11 pfam domains were
commonly mutated (Table 2). To determine the func-
tions overrepresented in our sets of significant mutated
domains, we obtained the annotations for all the do-
mains using DAVID [43,44]. A list of KEGG pathways
and gene annotation terms from the enrichment analysis
of significant domains for ovarian, breast and prostate
cancer can be found in the Additional file 7: Table S5. A
subsequent enrichment analysis of KEGG pathways an-
notated for significant PFAM domains in prostate cancer
revealed pathways related to Toll-like receptor signaling,
small cell lung cancer, complement and coagulation
cascades, etc. A similar analysis of GO terms annotated
for prostate cancer revealed an overrepresentation of
GO terms related to death, development process, and
cellular component organization among others. The
complete set of KEGG pathway and GO term annotation
for ovarian and breast cancer is tabulated in Additional
file 7: Table S5a, b.
As discussed in the previous section, core domains
were found to be less mutated in comparison to the per-
ipheral domains. We also investigated the presence of
significantly mutated domains in each core of the do-
main co-occurrence network. We calculated the percent-
ages of significant domains in each core of the DCN as
shown in Figure 6. Interestingly, we found that inner
cores 8, 9 and 10 did not contain any significantly mu-
tated domains. This indicates clearly that the inner core
domains have been highly conserved through evolution
and also less mutated in cancer. From the study done by
Benjamin A. et. al., it was found that highly connected
nodes in the domain interaction network had domains
which were conserved and also involved in important
biological roles within a cell [45].
Discussion
On analyzing genomes studies have shown that more
than 70% of eukaryotic proteins comprised of multiple
domains. Domain-domain interactions are now becom-
ing an upcoming trend of interest across numerous
studies [46-51]. Studies on protein-protein and domain-
domain interaction networks using graph models have
revealed that domain levels are the most important as-
pects of evolutionary selection. In addition to this, pro-
tein structural domains seem to have been the most
distinct and significant biological entities for interaction,
function and evolution [47]. Modeling of domain inter-
action networks have identified that domains are often in-
volved in the propagation of signal transduction and helps
determine the recognition specificity of each domain
Figure 4 Variation of normalized mutation values with the core order a) Ovarian cancer b) Breast cancer and c) Prostate cancer.
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Figure 5 Overlap between significantly mutated domains of ovarian, breast and prostate cancer.
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functional description of the global interactome [48].
By constructing and analyzing domain co-occurrence
networks we gain new and fundamental insights into the
qualitative arrangement and evolutionary utilization of
the proteome. Domain databases like Pfam and Inter-
dom provide comprehensive domain information but
mapping cancer SNPs to the individual domains mayTable 2 Significantly mutated domains found in all three
cancers studied











11 PF05111 Amelinhelp identify cancer targeted protein domains rather
than just the proteins. Domains with high relative rates
of mutation in three hormonal cancer types were identi-
fied along with their common domains. Recent studies
from Liu et al, 2014 revealed that the PDZ and LIM pro-
tein domain promotes breast cancer cell migration, inva-
sion and metastasis [52]. These two Pfam domains were
also listed among the significantly mutated domains of
the breast cancer.
Chi-squared goodness of fit test was employed to valid-
ate whether the observed and expected mutations are
statistically significant. The expected mutations were cal-
culated from the Homo sapiens DCN and the observed
mutations included all the three cancer SNPs. The ex-
pected and observed mutations in different k-cores were
calculated and plotted as shown in Figure 7. The observed
mutations (red curve) were found to be lower than the ex-
pected mutations (blue curve) as the core order increased.
This clearly suggests that the protein domain in the inner-
most core is less likely to get mutated as it was connected
to many other protein domains and also corresponding to
the set of domains with highest coreness. The p-value was
found to be less than 0.05 suggesting that the observed
mutation counts are not sampled from populations with
the expected frequencies.
Figure 6 The percentage of significantly mutated domains in k-core decomposition.
Figure 7 The expected versus observed significantly mutated domains in the core order.
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Analyzing mutations in domain co-occurrence network
helps in identifying crucial protein domains that aid in
the progression of cancer disease. Highly connected pro-
tein domains are found to be evolutionarily conserved in
the domain co-occurrence network. This implies that
protein domains in the inner core are more conserved
than the domains in the peripheral region. Significantly
mutated protein domains which were identified further
contributed to determining the disease target protein
domains in all the three cancer diseases. Comparing the
mutational landscape of somatic mutations in the pro-
tein domain co-occurrence network with the random
counterparts, our findings revealed that there is a statis-
tically significant difference between them.
The functional annotations obtained for all the signifi-
cantly mutated domains were seen to be involved in all the
three cancer diseases. Polymorphisms in inflammation-
related genes, including those in the Toll-like receptor
(TLR) signaling pathway, are hypothesized to be involved
in prostate carcinogenesis [53]. This Toll-like receptor
signaling pathway was enriched as one of the top ranked
KEGG pathway in our results. Similarly, the ribosome
pathway is also enriched as one of the top ranked KEGG
pathway. This ribosome pathway are activated in aggressive
human breast cancer cells [54] and comparison with
other pathways showed that the ribosome pathway
genes were up-regulated in ZR-75-1 (Human breast
carcinoma cell line) [55].
A recent study done by Pasta A et al [56], showed that
overexpressed genes in cancer stem cells (CSC) from pa-
tients with epithelial ovarian cancer are associated with
glucose uptake, oxidative phosphorylation (OXPHOS)
and fatty acid beta-oxidation. These overexpressed genes
are consistent with a metabolic profile dominated by
OXPHOS pathway [56]. In our results, ‘Complement and
coagulation cascades’ was the most frequently perturbed
pathway, as it was dysregulated in the ovarian cancer
[57] and these two pathways are also found to be
enriched in the significantly mutated domains. This
clearly suggests that the statistically significant do-
mains occur more commonly in cancer diseases. Fur-
ther studies are however recommended to investigate
the functional and structural constraints for the pro-
tein domain that evolves to be an inner core rather
than outer core domain of the DCN.Additional files
Additional file 1: Table S1. Chromosome start and end positions for
each predicted domain from homo sapiens proteome.
Additional file 2: Table S2a (sheet1). Mutation count and their
normalized score for each domain in Ovarian cancer. Table S2b (sheet2).
Mutation count and their normalized score for each domain in breastcancer. Table S2c (sheet3). Mutation count and their normalized score for
each domain in prostate cancer.
Additional file 3: Table S3a (sheet1). Local false discovery rate values
for each domain in ovarian cancer. Table S3b (sheet2). Local false discovery
rate values for each domain in breast cancer. Table S3c (sheet3). Local false
discovery rate values for each domain in prostate cancer.
Additional file 4: Figure S1a. Degree distribution plot for Homo
sapien’s DCN. Figure S1b. Shortest path length distribution plot for
Homo sapien’s DCN. Figure S1c. Average clustering co-efficient
distribution plot for Homo sapien’s DCN.
Additional file 5: Figure S2a. Correlation between each domain’s
normalized mutation rate and k-core values in ovarian cancer. Figure S2b.
Correlation between each domain’s normalized mutation rate and k-core
values in breast cancer. Figure S2c. Correlation between each domain’s
normalized mutation rate and k-core values in prostate cancer.
Additional file 6: Table S4a (sheet1). Significantly mutated domains
in ovarian cancer using local false discovery rate values. Table S4b (sheet2).
Significantly mutated domains in breast cancer using local false discovery
rate values. Table S4c (sheet3). Significantly mutated domains in prostate
cancer using local false discovery rate values.
Additional file 7: Table S5a (sheet1). KEGG pathways and gene
ontology annotations enriched in significantly mutated domains for the
ovarian cancer using DVAID tool. Table S5b (sheet2). KEGG pathways
and gene ontology annotations enriched in significantly mutated
domains for the breast cancer using DVAID tool. Table S5c (sheet3).
KEGG pathways and gene ontology annotations enriched in significantly
mutated domains for the prostate cancer using DVAID tool.
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